| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | RHCG GPR89B SLC29A3 MFSD14B SLC22A13 SLC22A23 SCN1A SCN5A SLC10A6 GPR89A SLC17A8 KCNN4 ANO5 CYB561A3 SLC14A2 SLC22A20P MFSD1 SLC33A1 ABCA9 ABCA8 SLC22A12 RHAG MFSD3 RHD | 3.00e-15 | 1180 | 57 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | RHCG GPR89B SLC29A3 MFSD14B SLC22A13 SLC22A23 SCN1A SCN5A SLC10A6 GPR89A SLC17A8 KCNN4 ANO5 CYB561A3 SLC14A2 SLC22A20P MFSD1 SLC33A1 ABCA9 ABCA8 SLC22A12 RHAG MFSD3 RHD | 2.13e-14 | 1289 | 57 | 24 | GO:0005215 |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 7.66e-07 | 7 | 57 | 3 | GO:0004769 | |
| GeneOntologyMolecularFunction | channel activity | 2.06e-06 | 525 | 57 | 10 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.10e-06 | 526 | 57 | 10 | GO:0022803 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 4.76e-06 | 12 | 57 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | cholesterol dehydrogenase activity | 8.01e-06 | 2 | 57 | 2 | GO:0102294 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 1.46e-05 | 17 | 57 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing C=C bonds | 2.07e-05 | 19 | 57 | 3 | GO:0016863 | |
| GeneOntologyMolecularFunction | ankyrin binding | 3.75e-05 | 23 | 57 | 3 | GO:0030506 | |
| GeneOntologyMolecularFunction | carbon dioxide transmembrane transporter activity | 4.79e-05 | 4 | 57 | 2 | GO:0035379 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 7.96e-05 | 5 | 57 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | 3-beta-hydroxy-delta5-steroid dehydrogenase (NAD+) activity | 1.19e-04 | 6 | 57 | 2 | GO:0003854 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 1.24e-04 | 34 | 57 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.87e-04 | 39 | 57 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 2.14e-04 | 103 | 57 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 2.22e-04 | 8 | 57 | 2 | GO:0047024 | |
| GeneOntologyMolecularFunction | 3-keto sterol reductase activity | 2.22e-04 | 8 | 57 | 2 | GO:0000253 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 2.22e-04 | 8 | 57 | 2 | GO:0004723 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.34e-04 | 42 | 57 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.74e-04 | 758 | 57 | 9 | GO:0015318 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 2.85e-04 | 9 | 57 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 2.85e-04 | 9 | 57 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.17e-04 | 459 | 57 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | uniporter activity | 3.55e-04 | 10 | 57 | 2 | GO:0015292 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.84e-04 | 627 | 57 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.00e-04 | 477 | 57 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity | 5.78e-04 | 57 | 57 | 3 | GO:0016860 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 9.09e-04 | 151 | 57 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.06e-03 | 17 | 57 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | 1.42e-03 | 766 | 57 | 8 | GO:0016491 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.44e-03 | 171 | 57 | 4 | GO:0015081 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.48e-03 | 293 | 57 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 1.62e-03 | 21 | 57 | 2 | GO:0005326 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.76e-03 | 793 | 57 | 8 | GO:0015075 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.81e-03 | 182 | 57 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.88e-03 | 184 | 57 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.37e-03 | 196 | 57 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.49e-03 | 26 | 57 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.61e-03 | 334 | 57 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 2.71e-03 | 337 | 57 | 5 | GO:0031625 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 3.09e-03 | 29 | 57 | 2 | GO:0004364 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 3.52e-03 | 358 | 57 | 5 | GO:0044389 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.99e-03 | 33 | 57 | 2 | GO:0033764 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.20e-03 | 230 | 57 | 4 | GO:0005516 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 5.24e-03 | 123 | 57 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.72e-03 | 127 | 57 | 3 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 7.20e-03 | 138 | 57 | 3 | GO:0016614 | |
| GeneOntologyMolecularFunction | retinoid binding | 8.30e-03 | 48 | 57 | 2 | GO:0005501 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 8.64e-03 | 49 | 57 | 2 | GO:0140359 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 8.64e-03 | 49 | 57 | 2 | GO:0019840 | |
| GeneOntologyMolecularFunction | sodium channel activity | 9.69e-03 | 52 | 57 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.04e-02 | 465 | 57 | 5 | GO:0046873 | |
| GeneOntologyMolecularFunction | amide binding | 1.04e-02 | 299 | 57 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.17e-02 | 165 | 57 | 3 | GO:0140375 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 1.23e-02 | 59 | 57 | 2 | GO:0008374 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.23e-02 | 59 | 57 | 2 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 1.23e-02 | 59 | 57 | 2 | GO:0015932 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 1.43e-02 | 178 | 57 | 3 | GO:0015399 | |
| GeneOntologyMolecularFunction | transferase activity, transferring alkyl or aryl (other than methyl) groups | 1.44e-02 | 64 | 57 | 2 | GO:0016765 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CBLIF GPR89B PPP3CA PPP3CC SLC22A23 SCN1A SCN5A SLC10A6 GPR89A SLC17A8 KCNN4 ANO5 TACR2 HSD3B1 HSD3B2 SELENON SLC22A20P SLC22A12 | 1.53e-08 | 1374 | 57 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | ammonium homeostasis | 3.98e-07 | 6 | 57 | 3 | GO:0097272 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 5.61e-06 | 13 | 57 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | RHCG CBLIF PPP3CA PPP3CC SCN1A SCN5A SLC17A8 KCNN4 ANO5 SELENON RHAG RHD | 1.75e-05 | 1017 | 57 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | RHCG CBLIF PPP3CA PPP3CC SCN1A SCN5A SLC17A8 KCNN4 SELENON RHAG RHD | 3.75e-05 | 922 | 57 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | carbon dioxide transmembrane transport | 4.49e-05 | 4 | 57 | 2 | GO:0035378 | |
| GeneOntologyBiologicalProcess | metal ion transport | CBLIF PPP3CA PPP3CC SCN1A SCN5A SLC10A6 SLC17A8 KCNN4 HSD3B1 HSD3B2 SELENON | 7.81e-05 | 1000 | 57 | 11 | GO:0030001 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC22A13 SLC10A6 SLC17A8 SELENON SLC22A20P SLC33A1 SLC22A12 RHAG | 8.07e-05 | 515 | 57 | 8 | GO:0015711 |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 9.96e-05 | 684 | 57 | 9 | GO:0010817 | |
| GeneOntologyBiologicalProcess | one-carbon compound transport | 1.03e-04 | 33 | 57 | 3 | GO:0019755 | |
| GeneOntologyBiologicalProcess | negative regulation of iron ion transport | 1.12e-04 | 6 | 57 | 2 | GO:0034757 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.50e-04 | 183 | 57 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell mediated immune response to tumor cell | 1.56e-04 | 7 | 57 | 2 | GO:0002842 | |
| GeneOntologyBiologicalProcess | androgen metabolic process | 1.58e-04 | 38 | 57 | 3 | GO:0008209 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 1.77e-04 | 577 | 57 | 8 | GO:0043269 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CBLIF GPR89B PPP3CA PPP3CC SCN1A SCN5A GPR89A SLC17A8 KCNN4 ANO5 SELENON | 2.04e-04 | 1115 | 57 | 11 | GO:0034220 |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion import across plasma membrane | 2.67e-04 | 9 | 57 | 2 | GO:1905949 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CBLIF PPP3CA PPP3CC SCN1A SCN5A SLC10A6 SLC17A8 KCNN4 HSD3B1 HSD3B2 SELENON | 2.81e-04 | 1157 | 57 | 11 | GO:0006812 |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 4.02e-04 | 493 | 57 | 7 | GO:0010959 | |
| GeneOntologyBiologicalProcess | urate transport | 4.06e-04 | 11 | 57 | 2 | GO:0015747 | |
| GeneOntologyBiologicalProcess | androgen biosynthetic process | 4.86e-04 | 12 | 57 | 2 | GO:0006702 | |
| GeneOntologyBiologicalProcess | regulation of iron ion transport | 4.86e-04 | 12 | 57 | 2 | GO:0034756 | |
| GeneOntologyBiologicalProcess | acetylcholine transport | 4.86e-04 | 12 | 57 | 2 | GO:0015870 | |
| GeneOntologyBiologicalProcess | regulation of muscle adaptation | 5.01e-04 | 133 | 57 | 4 | GO:0043502 | |
| GeneOntologyBiologicalProcess | amine transport | 5.60e-04 | 137 | 57 | 4 | GO:0015837 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import across plasma membrane | 5.74e-04 | 13 | 57 | 2 | GO:1905665 | |
| GeneOntologyBiologicalProcess | acetate ester transport | 5.74e-04 | 13 | 57 | 2 | GO:1901374 | |
| GeneOntologyBiologicalProcess | regulation of T cell mediated immune response to tumor cell | 6.68e-04 | 14 | 57 | 2 | GO:0002840 | |
| GeneOntologyBiologicalProcess | organic cation transport | 6.93e-04 | 145 | 57 | 4 | GO:0015695 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transport | 8.32e-04 | 266 | 57 | 5 | GO:0043270 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 8.47e-04 | 153 | 57 | 4 | GO:0098656 | |
| GeneOntologyBiologicalProcess | response to stimulus involved in regulation of muscle adaptation | 8.78e-04 | 16 | 57 | 2 | GO:0014874 | |
| GeneOntologyBiologicalProcess | L-ascorbic acid metabolic process | 8.78e-04 | 16 | 57 | 2 | GO:0019852 | |
| GeneOntologyBiologicalProcess | T cell mediated immune response to tumor cell | 9.94e-04 | 17 | 57 | 2 | GO:0002424 | |
| GeneOntologyBiologicalProcess | saliva secretion | 9.94e-04 | 17 | 57 | 2 | GO:0046541 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 1.10e-03 | 164 | 57 | 4 | GO:0043500 | |
| GeneOntologyBiologicalProcess | response to corticosterone | 1.12e-03 | 18 | 57 | 2 | GO:0051412 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 1.15e-03 | 286 | 57 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion import across plasma membrane | 1.24e-03 | 19 | 57 | 2 | GO:1905664 | |
| GeneOntologyBiologicalProcess | carbon dioxide transport | 1.24e-03 | 19 | 57 | 2 | GO:0015670 | |
| GeneOntologyBiologicalProcess | lactone metabolic process | 1.24e-03 | 19 | 57 | 2 | GO:1901334 | |
| GeneOntologyBiologicalProcess | non-canonical Wnt signaling pathway | 1.27e-03 | 77 | 57 | 3 | GO:0035567 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 1.28e-03 | 171 | 57 | 4 | GO:0043271 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | FZD6 MGST2 DHRS7 EBP NAV3 UGT2B7 JKAMP TMEM170A ANO5 HSD3B1 HSD3B2 MBOAT4 SELENON SLC33A1 AWAT1 | 1.77e-06 | 1327 | 57 | 15 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | FZD6 MGST2 DHRS7 EBP UGT2B7 JKAMP TMEM170A ANO5 HSD3B1 HSD3B2 MBOAT4 SELENON SLC33A1 AWAT1 | 6.98e-06 | 1293 | 57 | 14 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | FZD6 MGST2 DHRS7 EBP UGT2B7 JKAMP TMEM170A ANO5 HSD3B1 HSD3B2 MBOAT4 SELENON SLC33A1 AWAT1 | 7.36e-06 | 1299 | 57 | 14 | GO:0098827 |
| GeneOntologyCellularComponent | apical plasma membrane | 4.97e-05 | 487 | 57 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | calcineurin complex | 1.09e-04 | 6 | 57 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | apical part of cell | 1.92e-04 | 592 | 57 | 8 | GO:0045177 | |
| GeneOntologyCellularComponent | ankyrin-1 complex | 3.24e-04 | 10 | 57 | 2 | GO:0170014 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum membrane | 4.74e-04 | 12 | 57 | 2 | GO:0030868 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.60e-04 | 378 | 57 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | mitochondrial crista | 9.68e-04 | 17 | 57 | 2 | GO:0030061 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 9.68e-04 | 17 | 57 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.78e-03 | 320 | 57 | 5 | GO:0016323 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.76e-03 | 354 | 57 | 5 | GO:0009925 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.83e-03 | 29 | 57 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.94e-03 | 523 | 57 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | basal part of cell | 3.65e-03 | 378 | 57 | 5 | GO:0045178 | |
| GeneOntologyCellularComponent | transporter complex | 3.76e-03 | 550 | 57 | 6 | GO:1990351 | |
| HumanPheno | Hypochromia | 1.11e-05 | 12 | 20 | 3 | HP:0032231 | |
| HumanPheno | Increased red cell osmotic fragility | 1.44e-05 | 13 | 20 | 3 | HP:0005502 | |
| HumanPheno | Abnormal erythrocyte physiology | 2.29e-05 | 15 | 20 | 3 | HP:0020054 | |
| HumanPheno | Reduced haptoglobin level | 2.29e-05 | 15 | 20 | 3 | HP:0020181 | |
| HumanPheno | Abnormal circulating haptoglobin concentration | 2.81e-05 | 16 | 20 | 3 | HP:0020179 | |
| HumanPheno | Positive direct antiglobulin test | 4.38e-05 | 3 | 20 | 2 | HP:0032366 | |
| HumanPheno | Anti-erythrocyte autoantibody positivity | 4.38e-05 | 3 | 20 | 2 | HP:6000388 | |
| HumanPheno | Macrocytic anemia | 1.67e-04 | 74 | 20 | 4 | HP:0001972 | |
| HumanPheno | Increased circulating lactate dehydrogenase concentration | 2.48e-04 | 82 | 20 | 4 | HP:0025435 | |
| MousePheno | abnormal Meibomian gland physiology | 6.62e-07 | 6 | 46 | 3 | MP:0013391 | |
| MousePheno | dry eyes | 1.18e-05 | 14 | 46 | 3 | MP:0001337 | |
| MousePheno | increased tear production | 3.17e-05 | 3 | 46 | 2 | MP:0020219 | |
| MousePheno | abnormal sebaceous gland physiology | 3.66e-05 | 20 | 46 | 3 | MP:0002991 | |
| MousePheno | abnormal holocrine gland physiology | 3.66e-05 | 20 | 46 | 3 | MP:0013556 | |
| MousePheno | abnormal Meibomian gland morphology | 5.64e-05 | 23 | 46 | 3 | MP:0005252 | |
| MousePheno | abnormal skin sebaceous gland morphology | 7.29e-05 | 25 | 46 | 3 | MP:0009535 | |
| MousePheno | ventricular fibrillation | 2.20e-04 | 7 | 46 | 2 | MP:0006110 | |
| MousePheno | Meibomian gland atrophy | 2.20e-04 | 7 | 46 | 2 | MP:0001345 | |
| Domain | MFS_dom | MFSD14B SLC22A13 SLC22A23 SLC17A8 SLC22A20P MFSD1 SLC33A1 SLC22A12 MFSD3 | 2.19e-10 | 134 | 56 | 9 | IPR020846 |
| Domain | MFS | MFSD14B SLC22A13 SLC22A23 SLC17A8 SLC22A20P MFSD1 SLC22A12 MFSD3 | 1.08e-09 | 108 | 56 | 8 | PS50850 |
| Domain | - | 2.52e-09 | 7 | 56 | 4 | 1.10.3430.10 | |
| Domain | Ammonium/urea_transptr | 2.52e-09 | 7 | 56 | 4 | IPR029020 | |
| Domain | MFS | 1.11e-07 | 77 | 56 | 6 | IPR011701 | |
| Domain | MFS_1 | 1.11e-07 | 77 | 56 | 6 | PF07690 | |
| Domain | Ammonium_transpt | 2.54e-07 | 5 | 56 | 3 | IPR001905 | |
| Domain | Ammonium_transp | 2.54e-07 | 5 | 56 | 3 | PF00909 | |
| Domain | NH4_transpt_AmtB-like_dom | 2.54e-07 | 5 | 56 | 3 | IPR024041 | |
| Domain | RhesusRHD | 2.54e-07 | 5 | 56 | 3 | IPR002229 | |
| Domain | Sugar_tr | 3.97e-06 | 36 | 56 | 4 | PF00083 | |
| Domain | MFS_sugar_transport-like | 3.97e-06 | 36 | 56 | 4 | IPR005828 | |
| Domain | Frizzled | 4.14e-06 | 11 | 56 | 3 | IPR000539 | |
| Domain | Frizzled | 4.14e-06 | 11 | 56 | 3 | PF01534 | |
| Domain | Frizzled | 4.14e-06 | 11 | 56 | 3 | SM01330 | |
| Domain | Frizzled/SFRP | 1.39e-05 | 16 | 56 | 3 | IPR015526 | |
| Domain | FRI | 2.81e-05 | 20 | 56 | 3 | SM00063 | |
| Domain | - | 3.27e-05 | 21 | 56 | 3 | 1.10.2000.10 | |
| Domain | Frizzled_dom | 4.94e-05 | 24 | 56 | 3 | IPR020067 | |
| Domain | FZ | 4.94e-05 | 24 | 56 | 3 | PS50038 | |
| Domain | Fz | 4.94e-05 | 24 | 56 | 3 | PF01392 | |
| Domain | Na_trans_cytopl | 1.31e-04 | 6 | 56 | 2 | PF11933 | |
| Domain | 3Beta_OHSteriod_DH/Estase | 1.31e-04 | 6 | 56 | 2 | IPR002225 | |
| Domain | Na_trans_cytopl | 1.31e-04 | 6 | 56 | 2 | IPR024583 | |
| Domain | 3Beta_HSD | 1.31e-04 | 6 | 56 | 2 | PF01073 | |
| Domain | Na_channel_asu | 3.91e-04 | 10 | 56 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 3.91e-04 | 10 | 56 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 3.91e-04 | 10 | 56 | 2 | PF06512 | |
| Domain | ABC_A | 5.72e-04 | 12 | 56 | 2 | IPR026082 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 6.74e-04 | 13 | 56 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 6.74e-04 | 13 | 56 | 2 | PS00125 | |
| Domain | PP2Ac | 6.74e-04 | 13 | 56 | 2 | SM00156 | |
| Domain | GPCR_2-like | 7.74e-04 | 60 | 56 | 3 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 7.74e-04 | 60 | 56 | 3 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 8.12e-04 | 61 | 56 | 3 | PS50261 | |
| Domain | - | 1.65e-03 | 169 | 56 | 4 | 3.40.50.720 | |
| Domain | NAD(P)-bd_dom | 1.79e-03 | 173 | 56 | 4 | IPR016040 | |
| Domain | SUGAR_TRANSPORT_1 | 2.34e-03 | 24 | 56 | 2 | PS00216 | |
| Domain | Calcineurin-like_PHP_ApaH | 3.17e-03 | 28 | 56 | 2 | IPR004843 | |
| Domain | Metallophos | 3.17e-03 | 28 | 56 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 3.64e-03 | 30 | 56 | 2 | IPR029052 | |
| Domain | - | 3.64e-03 | 30 | 56 | 2 | 3.60.21.10 | |
| Domain | Sugar_transporter_CS | 4.13e-03 | 32 | 56 | 2 | IPR005829 | |
| Domain | ABC_TRANSPORTER_2 | 9.12e-03 | 48 | 56 | 2 | PS50893 | |
| Domain | ABC_tran | 9.12e-03 | 48 | 56 | 2 | PF00005 | |
| Domain | AAA+_ATPase | 9.23e-03 | 144 | 56 | 3 | IPR003593 | |
| Domain | AAA | 9.23e-03 | 144 | 56 | 3 | SM00382 | |
| Domain | ABC_TRANSPORTER_1 | 9.49e-03 | 49 | 56 | 2 | PS00211 | |
| Domain | ABC_transporter-like | 9.86e-03 | 50 | 56 | 2 | IPR003439 | |
| Domain | ADH_SHORT | 1.10e-02 | 53 | 56 | 2 | PS00061 | |
| Domain | adh_short | 1.18e-02 | 55 | 56 | 2 | PF00106 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 6.16e-07 | 238 | 44 | 8 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 8.66e-07 | 249 | 44 | 8 | M5988 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 1.57e-06 | 8 | 44 | 3 | M27433 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.67e-06 | 76 | 44 | 5 | MM15072 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | RHCG SLC29A3 SLC10A6 SLC17A8 ANO5 SLC14A2 SLC33A1 ABCA9 ABCA8 SLC22A12 RHAG | 5.49e-06 | 681 | 44 | 11 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 6.03e-06 | 84 | 44 | 5 | M27334 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 1.01e-05 | 14 | 44 | 3 | M47834 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | RHCG SLC29A3 SLC10A6 SLC17A8 ANO5 SLC14A2 SLC33A1 ABCA9 ABCA8 SLC22A12 RHAG | 1.15e-05 | 736 | 44 | 11 | M27287 |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.35e-05 | 99 | 44 | 5 | M27474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY | 1.54e-05 | 16 | 44 | 3 | M47823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO | 2.65e-05 | 19 | 44 | 3 | M47833 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 3.12e-05 | 20 | 44 | 3 | MM15155 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 3.63e-05 | 21 | 44 | 3 | M27401 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 8.80e-05 | 28 | 44 | 3 | M77 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.02e-04 | 151 | 44 | 5 | M19428 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 1.39e-04 | 85 | 44 | 4 | M48315 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 1.42e-04 | 6 | 44 | 2 | M27075 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 1.59e-04 | 34 | 44 | 3 | M27405 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.89e-04 | 36 | 44 | 3 | M39699 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.15e-04 | 177 | 44 | 5 | M27476 | |
| Pathway | WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE | 2.63e-04 | 8 | 44 | 2 | MM15965 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 3.38e-04 | 9 | 44 | 2 | MM15903 | |
| Pathway | WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS | 3.38e-04 | 9 | 44 | 2 | M46465 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 3.44e-04 | 44 | 44 | 3 | MM15878 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.67e-04 | 45 | 44 | 3 | MM15040 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.67e-04 | 45 | 44 | 3 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 3.92e-04 | 46 | 44 | 3 | M47409 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 4.15e-04 | 113 | 44 | 4 | M39669 | |
| Pathway | WP_STEROID_BIOSYNTHESIS | 4.22e-04 | 10 | 44 | 2 | M39538 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 4.22e-04 | 10 | 44 | 2 | M27076 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 4.22e-04 | 10 | 44 | 2 | M47954 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS | 5.14e-04 | 11 | 44 | 2 | M47895 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 5.14e-04 | 11 | 44 | 2 | MM14750 | |
| Pathway | REACTOME_ANDROGEN_BIOSYNTHESIS | 5.14e-04 | 11 | 44 | 2 | M504 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 5.72e-04 | 123 | 44 | 4 | MM14988 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 6.16e-04 | 12 | 44 | 2 | M47956 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 6.16e-04 | 12 | 44 | 2 | MM14749 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 6.65e-04 | 55 | 44 | 3 | M17807 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 6.65e-04 | 55 | 44 | 3 | M14933 | |
| Pathway | WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM | 7.27e-04 | 13 | 44 | 2 | M48060 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 8.46e-04 | 14 | 44 | 2 | MM1473 | |
| Pathway | REACTOME_CA2_PATHWAY | 9.44e-04 | 62 | 44 | 3 | M27321 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 9.74e-04 | 15 | 44 | 2 | M15181 | |
| Pathway | REACTOME_ANDROGEN_BIOSYNTHESIS | 9.74e-04 | 15 | 44 | 2 | MM14739 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 9.74e-04 | 15 | 44 | 2 | MM1387 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 1.09e-03 | 146 | 44 | 4 | M27288 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.11e-03 | 16 | 44 | 2 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47449 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 1.11e-03 | 16 | 44 | 2 | M39815 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 1.13e-03 | 66 | 44 | 3 | M39642 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 1.26e-03 | 17 | 44 | 2 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.26e-03 | 17 | 44 | 2 | M5940 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.34e-03 | 70 | 44 | 3 | M16794 | |
| Pathway | WP_GPCRS_NONODORANT | 1.37e-03 | 266 | 44 | 5 | MM15843 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.41e-03 | 18 | 44 | 2 | M3430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.41e-03 | 18 | 44 | 2 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.41e-03 | 18 | 44 | 2 | M5290 | |
| Pathway | WP_CHOLESTEROL_SYNTHESIS_DISORDERS | 1.41e-03 | 18 | 44 | 2 | M45528 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.41e-03 | 18 | 44 | 2 | MM1385 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.46e-03 | 72 | 44 | 3 | M9257 | |
| Pathway | WP_GPCRS_ORPHAN | 1.57e-03 | 19 | 44 | 2 | MM15991 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.57e-03 | 19 | 44 | 2 | M47543 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS | 1.57e-03 | 19 | 44 | 2 | M47809 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.75e-03 | 20 | 44 | 2 | MM1445 | |
| Pathway | WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS | 1.75e-03 | 20 | 44 | 2 | M48330 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.93e-03 | 21 | 44 | 2 | M47542 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.93e-03 | 21 | 44 | 2 | M11650 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY | 2.31e-03 | 23 | 44 | 2 | M47806 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 2.34e-03 | 85 | 44 | 3 | MM15041 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.49e-03 | 183 | 44 | 4 | M39588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY | 2.52e-03 | 24 | 44 | 2 | M47487 | |
| Pathway | REACTOME_DARPP_32_EVENTS | 2.52e-03 | 24 | 44 | 2 | M751 | |
| Pathway | WNT_SIGNALING | 2.67e-03 | 89 | 44 | 3 | M5493 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.73e-03 | 25 | 44 | 2 | MM1441 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.73e-03 | 25 | 44 | 2 | M1547 | |
| Pathway | REACTOME_PCP_CE_PATHWAY | 2.94e-03 | 92 | 44 | 3 | M27322 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.95e-03 | 26 | 44 | 2 | M17941 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.95e-03 | 26 | 44 | 2 | MM1371 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 3.12e-03 | 94 | 44 | 3 | M797 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 3.66e-03 | 29 | 44 | 2 | MM1495 | |
| Pathway | KEGG_MELANOGENESIS | 3.82e-03 | 101 | 44 | 3 | M7761 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 3.82e-03 | 101 | 44 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 3.82e-03 | 101 | 44 | 3 | M39387 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 3.92e-03 | 30 | 44 | 2 | M9664 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 4.18e-03 | 31 | 44 | 2 | M877 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 4.45e-03 | 32 | 44 | 2 | MM1355 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 4.45e-03 | 32 | 44 | 2 | M27455 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 4.45e-03 | 32 | 44 | 2 | M39521 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.49e-03 | 107 | 44 | 3 | MM14595 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 4.73e-03 | 33 | 44 | 2 | M9494 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 4.73e-03 | 109 | 44 | 3 | M18788 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 4.85e-03 | 110 | 44 | 3 | MM15977 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 4.98e-03 | 111 | 44 | 3 | M48065 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 5.01e-03 | 34 | 44 | 2 | M10287 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 5.01e-03 | 34 | 44 | 2 | MM1399 | |
| Pathway | REACTOME_METABOLISM_OF_STEROID_HORMONES | 5.61e-03 | 36 | 44 | 2 | M27081 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 5.61e-03 | 36 | 44 | 2 | M1443 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 5.63e-03 | 116 | 44 | 3 | MM15863 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.65e-03 | 702 | 44 | 7 | M746 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 5.76e-03 | 117 | 44 | 3 | M39530 | |
| Pubmed | Evolutionary conservation and diversification of Rh family genes and proteins. | 4.39e-08 | 5 | 58 | 3 | 16227429 | |
| Pubmed | 4.39e-08 | 5 | 58 | 3 | 10395542 | ||
| Pubmed | 1.53e-07 | 7 | 58 | 3 | 15370539 | ||
| Pubmed | Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis. | 2.45e-07 | 8 | 58 | 3 | 10559494 | |
| Pubmed | Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis. | 5.24e-07 | 10 | 58 | 3 | 17532316 | |
| Pubmed | Expression of Frizzled genes in developing and postnatal hair follicles. | 5.24e-07 | 10 | 58 | 3 | 15245425 | |
| Pubmed | ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. | 7.19e-07 | 11 | 58 | 3 | 22575959 | |
| Pubmed | Molecular determinants of WNT9b responsiveness in nephron progenitor cells. | 7.19e-07 | 11 | 58 | 3 | 30978219 | |
| Pubmed | Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells. | 7.19e-07 | 11 | 58 | 3 | 24860427 | |
| Pubmed | 7.19e-07 | 11 | 58 | 3 | 17582687 | ||
| Pubmed | 7.19e-07 | 11 | 58 | 3 | 17576136 | ||
| Pubmed | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. | 2.73e-06 | 2 | 58 | 2 | 16054936 | |
| Pubmed | Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. | 2.73e-06 | 2 | 58 | 2 | 14665668 | |
| Pubmed | Frizzled-4 is required for normal bone acquisition despite compensation by Frizzled-8. | 2.73e-06 | 2 | 58 | 2 | 31985040 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 28253274 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 33712547 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11133676 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 20660004 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 27981419 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 2066113 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11912155 | ||
| Pubmed | Chaperones rejuvenate folding and activity of 3-β hydroxysteroid dehydrogenase 2. | 2.73e-06 | 2 | 58 | 2 | 23485106 | |
| Pubmed | Association of the variations in the HSD3β gene with primary aldosteronism. | 2.73e-06 | 2 | 58 | 2 | 24006038 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1944309 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 7626443 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8647315 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 7491113 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12846905 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12530651 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12130520 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18524572 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 34550611 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 19414525 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12204676 | ||
| Pubmed | Isolation and characterization of several members of the murine Hsd3b gene family. | 2.73e-06 | 2 | 58 | 2 | 8924213 | |
| Pubmed | GPHR is a novel anion channel critical for acidification and functions of the Golgi apparatus. | 2.73e-06 | 2 | 58 | 2 | 18794847 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 18778748 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9029734 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9029733 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 2243100 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 14764797 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 10103023 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9075693 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12205101 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1417776 | ||
| Pubmed | High carrier frequency of a nonsense p.Trp230* variant in HSD3B2 gene in Ossetians. | 2.73e-06 | 2 | 58 | 2 | 37274334 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 1924345 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8145763 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 24075909 | ||
| Pubmed | The challenge of understanding ammonium homeostasis and the role of the Rh glycoproteins. | 2.73e-06 | 2 | 58 | 2 | 16564724 | |
| Pubmed | 3β-Hydroxysteroid dehydrogenase isoforms in human aldosterone-producing adenoma. | 2.73e-06 | 2 | 58 | 2 | 25458695 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 17689071 | ||
| Pubmed | The human Rhesus-associated RhAG protein and a kidney homologue promote ammonium transport in yeast. | 2.73e-06 | 2 | 58 | 2 | 11062476 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 22572823 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16478974 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12050213 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 7608280 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 30851938 | ||
| Pubmed | 6.63e-06 | 22 | 58 | 3 | 17064353 | ||
| Pubmed | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. | 6.95e-06 | 73 | 58 | 4 | 19027726 | |
| Pubmed | Mechanisms of ammonia and ammonium transport by rhesus-associated glycoproteins. | 8.19e-06 | 3 | 58 | 2 | 26354748 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32185219 | ||
| Pubmed | Neuropsin (Opn5): a novel opsin identified in mammalian neural tissue. | 8.19e-06 | 3 | 58 | 2 | 14623103 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 29679912 | ||
| Pubmed | Relative CO₂/NH₃ permeabilities of human RhAG, RhBG and RhCG. | 8.19e-06 | 3 | 58 | 2 | 24077989 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 32220963 | ||
| Pubmed | SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy. | 8.19e-06 | 3 | 58 | 2 | 25823783 | |
| Pubmed | Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy. | 8.19e-06 | 3 | 58 | 2 | 22638611 | |
| Pubmed | The proline-rich N-terminal sequence of calcineurin Abeta determines substrate binding. | 8.19e-06 | 3 | 58 | 2 | 19154138 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 19807729 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 25319929 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22188362 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 24498049 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18930903 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 2162844 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 22875961 | ||
| Pubmed | Evolutionary history of the Rh blood group-related genes in vertebrates. | 8.19e-06 | 3 | 58 | 2 | 10970100 | |
| Pubmed | The members of the RH gene family (RH50 and RH30) followed different evolutionary pathways. | 8.19e-06 | 3 | 58 | 2 | 9929383 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 1659808 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 15929723 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 3146980 | ||
| Pubmed | Conserved evolution of the Rh50 gene compared to its homologous Rh blood group gene. | 8.19e-06 | 3 | 58 | 2 | 9705835 | |
| Pubmed | Modulation of steroidogenic enzymes in murine lymphoid organs after immune activation. | 8.19e-06 | 3 | 58 | 2 | 19172483 | |
| Pubmed | 8.69e-06 | 24 | 58 | 3 | 9096311 | ||
| Pubmed | 8.69e-06 | 24 | 58 | 3 | 8626800 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 9.86e-06 | 25 | 58 | 3 | 12812787 | |
| Pubmed | 1.56e-05 | 29 | 58 | 3 | 18364260 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11773066 | ||
| Pubmed | Hormonal regulation of steroidogenic enzyme gene expression in Leydig cells. | 1.64e-05 | 4 | 58 | 2 | 22217834 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 16115200 | ||
| Pubmed | Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver. | 1.64e-05 | 4 | 58 | 2 | 16445568 | |
| Pubmed | Transport characteristics of mammalian Rh and Rh glycoproteins expressed in heterologous systems. | 1.64e-05 | 4 | 58 | 2 | 16563829 | |
| Pubmed | Cerebellar Neurodegeneration and Neuronal Circuit Remodeling in Golgi pH Regulator-Deficient Mice. | 1.64e-05 | 4 | 58 | 2 | 31118204 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 20023637 | ||
| Pubmed | Brain-derived neurotrophic factor: A steroidogenic regulator of Leydig cells. | 1.64e-05 | 4 | 58 | 2 | 30628054 | |
| Pubmed | An mRNA differential display strategy for cloning genes expressed during mouse gonad development. | 1.64e-05 | 4 | 58 | 2 | 9303351 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 37117756 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 11714752 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 12719424 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 18234671 | ||
| Interaction | YIPF6 interactions | 9.59e-07 | 117 | 57 | 6 | int:YIPF6 | |
| Interaction | ARLN interactions | 5.84e-06 | 91 | 57 | 5 | int:ARLN | |
| Interaction | TRARG1 interactions | 1.54e-05 | 111 | 57 | 5 | int:TRARG1 | |
| Interaction | CACNA1D interactions | 4.16e-05 | 24 | 57 | 3 | int:CACNA1D | |
| Interaction | NAT8 interactions | 1.10e-04 | 33 | 57 | 3 | int:NAT8 | |
| Interaction | TSNARE1 interactions | 1.56e-04 | 37 | 57 | 3 | int:TSNARE1 | |
| Interaction | C16orf74 interactions | 1.64e-04 | 7 | 57 | 2 | int:C16orf74 | |
| Interaction | CYP4F2 interactions | 1.69e-04 | 38 | 57 | 3 | int:CYP4F2 | |
| Interaction | TMEM167B interactions | 1.97e-04 | 40 | 57 | 3 | int:TMEM167B | |
| Interaction | TMEM119 interactions | 2.18e-04 | 8 | 57 | 2 | int:TMEM119 | |
| Interaction | SMAGP interactions | 2.28e-04 | 42 | 57 | 3 | int:SMAGP | |
| Interaction | TMEM229B interactions | 2.62e-04 | 44 | 57 | 3 | int:TMEM229B | |
| Interaction | YIPF1 interactions | 2.62e-04 | 44 | 57 | 3 | int:YIPF1 | |
| Interaction | GIMAP1 interactions | 2.80e-04 | 45 | 57 | 3 | int:GIMAP1 | |
| Interaction | LRP10 interactions | 3.15e-04 | 115 | 57 | 4 | int:LRP10 | |
| Interaction | HSD3B1 interactions | 3.49e-04 | 10 | 57 | 2 | int:HSD3B1 | |
| Interaction | UNC50 interactions | 3.60e-04 | 49 | 57 | 3 | int:UNC50 | |
| Interaction | TSPAN31 interactions | 4.06e-04 | 51 | 57 | 3 | int:TSPAN31 | |
| Interaction | SCN10A interactions | 4.25e-04 | 11 | 57 | 2 | int:SCN10A | |
| Interaction | TMEM208 interactions | 4.80e-04 | 54 | 57 | 3 | int:TMEM208 | |
| Interaction | FMO1 interactions | 5.09e-04 | 12 | 57 | 2 | int:FMO1 | |
| Interaction | TREX1 interactions | 5.35e-04 | 56 | 57 | 3 | int:TREX1 | |
| Interaction | TMEM216 interactions | 6.50e-04 | 246 | 57 | 5 | int:TMEM216 | |
| Interaction | NALCN interactions | 7.00e-04 | 14 | 57 | 2 | int:NALCN | |
| Interaction | ZDHHC24 interactions | 7.00e-04 | 14 | 57 | 2 | int:ZDHHC24 | |
| Interaction | SERP2 interactions | 7.55e-04 | 63 | 57 | 3 | int:SERP2 | |
| Interaction | CREB3L3 interactions | 7.55e-04 | 63 | 57 | 3 | int:CREB3L3 | |
| Interaction | MS4A13 interactions | 7.91e-04 | 64 | 57 | 3 | int:MS4A13 | |
| Interaction | SCN11A interactions | 8.06e-04 | 15 | 57 | 2 | int:SCN11A | |
| Interaction | SERP1 interactions | 8.65e-04 | 66 | 57 | 3 | int:SERP1 | |
| Interaction | SACM1L interactions | 9.01e-04 | 152 | 57 | 4 | int:SACM1L | |
| Interaction | ORMDL1 interactions | 9.04e-04 | 67 | 57 | 3 | int:ORMDL1 | |
| Interaction | CBLIF interactions | 9.19e-04 | 16 | 57 | 2 | int:CBLIF | |
| Cytoband | 1p13.1 | 8.08e-04 | 33 | 58 | 2 | 1p13.1 | |
| Cytoband | 6p12.3 | 9.61e-04 | 36 | 58 | 2 | 6p12.3 | |
| Cytoband | 10q22.1 | 1.57e-03 | 46 | 58 | 2 | 10q22.1 | |
| Cytoband | 14q23.1 | 1.63e-03 | 47 | 58 | 2 | 14q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p12 | 2.07e-03 | 53 | 58 | 2 | chr1p12 | |
| Cytoband | 1q21.1 | 2.83e-03 | 62 | 58 | 2 | 1q21.1 | |
| Cytoband | 11q13.1 | 2.92e-03 | 63 | 58 | 2 | 11q13.1 | |
| GeneFamily | Solute carriers | RHCG SLC29A3 SLC22A13 SLC22A23 SLC10A6 SLC17A8 SLC14A2 SLC22A20P SLC33A1 SLC22A12 RHAG | 3.16e-09 | 395 | 46 | 11 | 752 |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 2.51e-06 | 11 | 46 | 3 | 286 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 4.11e-05 | 76 | 46 | 4 | 743 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.25e-04 | 9 | 46 | 2 | 1203 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 4.85e-04 | 13 | 46 | 2 | 693 | |
| GeneFamily | ATP binding cassette subfamily A | 5.65e-04 | 14 | 46 | 2 | 805 | |
| GeneFamily | Glutathione S-transferases | 1.83e-03 | 25 | 46 | 2 | 567 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 3.99e-03 | 37 | 46 | 2 | 454 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_DN | 5.90e-06 | 314 | 58 | 7 | M14279 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 2.25e-05 | 703 | 58 | 9 | MM1055 | |
| ToppCell | mild_COVID-19-RBC|World / disease group, cell group and cell class (v2) | 4.48e-07 | 117 | 58 | 5 | 85210be67ddc31903764b7fa6d7029d9656753d3 | |
| ToppCell | mild_COVID-19-RBC|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.08e-07 | 120 | 58 | 5 | cccea760901558ec18d5cbb71c7971c5a51da571 | |
| ToppCell | droplet-Marrow-nan-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-06 | 176 | 58 | 5 | f92063b72ebfeb9b192281dc63d6bf2759c78554 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.74e-06 | 180 | 58 | 5 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 180 | 58 | 5 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-06 | 180 | 58 | 5 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-06 | 189 | 58 | 5 | 8a38baee58a27c2fa3f4bd131ab9f15723ed9295 | |
| ToppCell | E12.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.26e-05 | 149 | 58 | 4 | fb75c1b91b8a0c8221fbbc350666799727b21120 | |
| ToppCell | E12.5-Hematopoietic-Erythroid|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.26e-05 | 149 | 58 | 4 | 08e7f76b7e4b53ff734d50dbc853ecfdeb4b371b | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 165 | 58 | 4 | 4f95c2fe5ab4416c736fe0d1936695a2b26777eb | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 165 | 58 | 4 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 165 | 58 | 4 | 3e913b49a868fdd5589200ae3e9be77c0938ba14 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 165 | 58 | 4 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | 08fe8fa43c343c03f9a2f0b982192fde04a7c027 | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | d4053b2fffb19e0376b8ceb92e87ec4447d96a3e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.80e-05 | 168 | 58 | 4 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-05 | 168 | 58 | 4 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.80e-05 | 168 | 58 | 4 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | droplet-Kidney-nan-18m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 173 | 58 | 4 | 60e427f6c7d953cef5f692043670ff0b49cdce72 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.96e-05 | 175 | 58 | 4 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 7.96e-05 | 175 | 58 | 4 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.96e-05 | 175 | 58 | 4 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 7.96e-05 | 175 | 58 | 4 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 178 | 58 | 4 | ff80288fb54cdd25ce3e1c638b67d5db2a456e48 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.47e-05 | 183 | 58 | 4 | b52d7683dc6652766e814ebe935c264ecd610c4b | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.47e-05 | 183 | 58 | 4 | 1d77d8d8c8f78f43dd8864e76f294ee66d4942c2 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____plasma_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | edb0069c66b1465dcc0bb5881417c6b17184fd74 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Cycling_definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.67e-05 | 184 | 58 | 4 | 238eba615b4e04967d44ac7858a6673bdd7f67e9 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.67e-05 | 184 | 58 | 4 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.87e-05 | 185 | 58 | 4 | c4bf3ac684c1a8876b51f7af4d3a62dc47e961ee | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.87e-05 | 185 | 58 | 4 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 9.87e-05 | 185 | 58 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.00e-04 | 69 | 58 | 3 | 10d5fccc1fa10ffc9051df42dd0e5046d97ec4af | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.00e-04 | 69 | 58 | 3 | 9d7e911434c6b18327fa7adaec5c449e0c300919 | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 1.01e-04 | 186 | 58 | 4 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | severe_influenza-RBC|World / disease group, cell group and cell class (v2) | 1.03e-04 | 187 | 58 | 4 | f846750575f318503d21ade30f5bfd2e1d4c84af | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.03e-04 | 187 | 58 | 4 | edb0ab0154542b1c0b3a2c216c4a60f0f06290b3 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.03e-04 | 187 | 58 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 188 | 58 | 4 | 5d6faf45a9c0794b0c30b0a0601c10afbb8aa9ed | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 188 | 58 | 4 | a0873783f0a2cd852563c05a275dddc72905ced2 | |
| ToppCell | Influenza_Severe-RBC|World / Disease group and Cell class | 1.05e-04 | 188 | 58 | 4 | f0438e6a77ee1f0456cb65926685266fff470983 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 188 | 58 | 4 | 29d804232d974a8c0029300345b287005b09bade | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-04 | 189 | 58 | 4 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.07e-04 | 189 | 58 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.09e-04 | 190 | 58 | 4 | a34293601aefe5fb5c400c14091294b9ddaa195b | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.09e-04 | 190 | 58 | 4 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.12e-04 | 191 | 58 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-04 | 192 | 58 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 1.14e-04 | 192 | 58 | 4 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-04 | 193 | 58 | 4 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 193 | 58 | 4 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-04 | 193 | 58 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | severe_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2) | 1.16e-04 | 193 | 58 | 4 | ffb0b3c2cce13b6891157f0fede2600f3938670e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-04 | 193 | 58 | 4 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-04 | 194 | 58 | 4 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.21e-04 | 195 | 58 | 4 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.21e-04 | 195 | 58 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.21e-04 | 195 | 58 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 196 | 58 | 4 | ae46d4b00be92e64e46252dcc156161b171eded4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 196 | 58 | 4 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-04 | 196 | 58 | 4 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.23e-04 | 196 | 58 | 4 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Chat.Synpr-Slc5a7_(Neuron.Gad1Gad2-Chat.Synpr-Slc5a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 74 | 58 | 3 | 0d705c42e7741b861ba5a9f1af83b2c5c6f23fb6 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Chat.Synpr-Slc5a7_(Neuron.Gad1Gad2-Chat.Synpr-Slc5a7)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 74 | 58 | 3 | c49bda52aa4ead9483c2f27d63458034e75699bd | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-04 | 197 | 58 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.26e-04 | 197 | 58 | 4 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-04 | 198 | 58 | 4 | 1a39a98beef68e1e6d3adc25270a3336fcc5baf4 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-04 | 198 | 58 | 4 | dd80fd9671ee863aebcf4c1023d3e004cc2ee709 | |
| ToppCell | Control_saline-Hematopoietic_Erythro-Megakary|Control_saline / Treatment groups by lineage, cell group, cell type | 1.28e-04 | 198 | 58 | 4 | cfc2a860bae883299987d3e374d0476ca20e1bdd | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 198 | 58 | 4 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.28e-04 | 198 | 58 | 4 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 198 | 58 | 4 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.28e-04 | 198 | 58 | 4 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | 565404c155dfac57c020a8f2d09cbf756da20ffd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 199 | 58 | 4 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 1.31e-04 | 199 | 58 | 4 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | f894c88ecc7fd0edca28587801fa59352d10f750 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | 6c174dbcc25b980f10a3d1dfe39e613acac73bb6 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | 284ee9632413f6404fc0b0c7c393ad813db834f2 | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 1.31e-04 | 199 | 58 | 4 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.31e-04 | 199 | 58 | 4 | 2b754670fe77c2301afcdcfc73a1e52cc0cd1de3 | |
| ToppCell | Influenza-Influenza_Severe-Others|Influenza_Severe / Disease, condition lineage and cell class | 1.33e-04 | 200 | 58 | 4 | 8909da4f7da3bc469a2becb4cfa5c25012af5845 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-04 | 200 | 58 | 4 | b5f2892bc45fda5ae05e269b840305a608a07c37 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-04 | 200 | 58 | 4 | 9ce1f91991637fc3af0f6a80a85e1a44276fe412 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | f100edfd2b3b742458cbbf34de9c403c4d272d3c | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-04 | 200 | 58 | 4 | fdf3e60cf94f398a56c0fa72813d0459f5ce081b | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | fa1eaf008b54bdf7bbcdec8134460c5f64490de9 | |
| ToppCell | Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-04 | 200 | 58 | 4 | 199165be1aef8497af71b74690a11de18fbe073c | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | f99e214eb680fd82a33f2b1524fbfca265d1cc42 | |
| ToppCell | LPS_IL1RA-Hematopoietic_Erythro-Megakary|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | d85074b362b11e5a523a5325d203a61aa2759a7a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.33e-04 | 200 | 58 | 4 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Erythrocytes|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.33e-04 | 200 | 58 | 4 | a9edac2f5e009662df452ec032a80e855cdac28f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 1.33e-04 | 200 | 58 | 4 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | droplet-Fat-Mat-18m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 89 | 58 | 3 | 56039e126e6f3e8fcaf3c47237c980e514512536 | |
| Computational | Catalytic activities / metabolism. | 1.67e-04 | 329 | 28 | 6 | MODULE_212 | |
| Drug | p-Aminohippuric Acid | 1.86e-06 | 10 | 58 | 3 | ctd:D010130 | |
| Drug | 1-norokadaone | 3.40e-06 | 12 | 58 | 3 | CID003309928 | |
| Drug | Phenytoin | 6.38e-06 | 2 | 58 | 2 | DB00252 | |
| Drug | 3-oxo-delta 5-steroid | 6.38e-06 | 2 | 58 | 2 | CID000439372 | |
| Drug | Probenecid | 1.55e-05 | 59 | 58 | 4 | ctd:D011339 | |
| Drug | AC1NSK22 | 2.43e-05 | 66 | 58 | 4 | CID005311131 | |
| Drug | estrone sulfate | 2.68e-05 | 23 | 58 | 3 | ctd:C017296 | |
| Drug | NSC9567 | 2.99e-05 | 141 | 58 | 5 | CID000003001 | |
| Drug | turosteride | 3.81e-05 | 4 | 58 | 2 | CID000065986 | |
| Drug | LX201 | 3.81e-05 | 4 | 58 | 2 | CID006440291 | |
| Drug | Trilostane | 3.81e-05 | 4 | 58 | 2 | DB01108 | |
| Drug | C05489 | 3.81e-05 | 4 | 58 | 2 | CID000440708 | |
| Drug | suppressor of FK506 1 | 3.81e-05 | 4 | 58 | 2 | CID000419462 | |
| Drug | botrydial | 6.35e-05 | 5 | 58 | 2 | CID000185781 | |
| Drug | 17alpha, 21-dihydroxypregnenolone | 6.35e-05 | 5 | 58 | 2 | CID000192735 | |
| Drug | 21-hydroxypregnenolone | 9.50e-05 | 6 | 58 | 2 | CID000150891 | |
| Drug | 16alpha-OHAD | 9.50e-05 | 6 | 58 | 2 | CID000160789 | |
| Drug | 2,2,2-trifluoroethyl phosphate | 1.33e-04 | 7 | 58 | 2 | CID000151044 | |
| Drug | 16 alpha-hydroxydehydroepiandrosterone | 1.33e-04 | 7 | 58 | 2 | CID000102030 | |
| Drug | viridiflorol | 1.33e-04 | 7 | 58 | 2 | CID000092812 | |
| Drug | 1-benzothiophene-2-carboxamide | 1.33e-04 | 7 | 58 | 2 | CID000237073 | |
| Drug | AC1L1HSJ | 1.61e-04 | 107 | 58 | 4 | CID000004272 | |
| Disease | Rh Deficiency Syndrome | 9.85e-06 | 3 | 54 | 2 | C0272052 | |
| Disease | Rh-Null, Regulator Type | 9.85e-06 | 3 | 54 | 2 | C1849387 | |
| Disease | hearing impairment | 3.18e-05 | 98 | 54 | 4 | C1384666 | |
| Disease | hepatitis A virus cellular receptor 1 measurement | 3.28e-05 | 5 | 54 | 2 | EFO_0010601 | |
| Disease | hyperprolactinemia (biomarker_via_orthology) | 1.17e-04 | 9 | 54 | 2 | DOID:12700 (biomarker_via_orthology) | |
| Disease | gestational age | 1.21e-04 | 138 | 54 | 4 | EFO_0005112 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.47e-04 | 10 | 54 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.14e-04 | 12 | 54 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | vision disorder | 3.88e-04 | 16 | 54 | 2 | MONDO_0021084 | |
| Disease | partial epilepsy | 4.39e-04 | 17 | 54 | 2 | EFO_0004263 | |
| Disease | childhood aggressive behaviour measurement | 5.89e-04 | 89 | 54 | 3 | EFO_0007663 | |
| Disease | gastroesophageal reflux disease | 8.51e-04 | 101 | 54 | 3 | EFO_0003948 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FFSFVFWPFSLKLLW | 111 | O00400 | |
| SRWSLPLTLMYWIGF | 281 | P26439 | |
| IPWYFLSGATVTLWM | 456 | Q75V66 | |
| DSRWSFPLSLMYWIG | 281 | P14060 | |
| FWLSWGLMYAGFILI | 266 | Q8IUA7 | |
| FLLVTYLWQYMPTWA | 291 | Q9Y394 | |
| MLWFGGCSWALYLFL | 46 | O15554 | |
| KLAVFDLDYTLWPFW | 6 | Q86V88 | |
| WFMDLWNYSLVPYIL | 2256 | Q8IVL0 | |
| SLIYTMPWINYFQLW | 116 | Q9H114 | |
| ISMIDYLLWPWFERL | 171 | Q9H4Y5 | |
| IWAYASFWTTMPLVG | 156 | Q6U736 | |
| LLLSYVKEFWWFPHM | 376 | P52848 | |
| FMLLYAWYSWPNVVL | 81 | Q9H3U5 | |
| FSWPQLFLLLAATYW | 161 | Q96ES6 | |
| IWTSLFMWFFYALIP | 11 | Q6UXL0 | |
| WWEYMPSGFTDASFL | 81 | Q6PIJ6 | |
| FLLMYFFGMASSIWW | 306 | Q9ULV1 | |
| FMLLYFFTMAGTVWW | 286 | O60353 | |
| LLVYFFGMASSIWWV | 401 | Q9H461 | |
| MAWFALYLLSLLWAT | 1 | P27352 | |
| LFSCLLWLTFMYFFW | 111 | B7ZAQ6 | |
| LWLTFMYFFWKLGDP | 116 | B7ZAQ6 | |
| LFSCLLWLTFMYFFW | 111 | P0CG08 | |
| LWLTFMYFFWKLGDP | 116 | P0CG08 | |
| WYRFFCLWEKLPTSM | 666 | O75417 | |
| VLYFAWLFLDWKTPE | 46 | Q58HT5 | |
| SMYYRTILLDSNWWP | 276 | Q8N4S9 | |
| MEWLWLFFLHPISFY | 1 | Q96T53 | |
| FAVFLLPWASMWLRS | 136 | Q8NBI2 | |
| SIQFLFAQYMPEWLW | 296 | Q3SXM5 | |
| WFYFVFMNALWLVLP | 186 | Q15125 | |
| SVPFFLCFLYSWWLA | 266 | Q96S37 | |
| FYFWALPESARWLLT | 266 | Q9Y226 | |
| ISAPFLIFFLYSWWL | 256 | A6NK97 | |
| EAPFYEEWWFLLVMA | 2001 | Q7Z5N4 | |
| YWLPNFMDVFTWSLP | 341 | Q08209 | |
| PWWYFAMISVSGVFS | 131 | Q5SR56 | |
| FSMPSWQLALWATAY | 26 | P21452 | |
| PIFIITLWMAGWYFN | 61 | Q99735 | |
| LPWNFFITAKEYWMF | 66 | Q9BZD2 | |
| CSFPEMWYGVFLWAL | 41 | Q8WVE7 | |
| MWYGVFLWALVSSLF | 46 | Q8WVE7 | |
| MLLYWSIFPESLRWL | 356 | A1A5C7 | |
| DPWNWLDFSVIIMAY | 191 | Q14524 | |
| FSNIFLIWDCSPYWL | 741 | P35498 | |
| WLSWGLLYAGFIFIM | 266 | O94911 | |
| PYWLPNFMDVFTWSL | 336 | P48454 | |
| LMWSLSYIFFPDALW | 221 | A0A1B0GVZ9 | |
| LGALFLWMFWPSFNS | 211 | Q02161 | |
| WWIIPSELSMFTGYL | 221 | Q9NZV5 | |
| MDFWLWPLYFLPVSG | 1 | O60667 | |
| LFLWMFWPSFNSAIA | 216 | Q02094 | |
| MPLCIYLYTWSWSLQ | 141 | Q3KNW5 | |
| AMIGTLFLWMYWPSF | 221 | Q9UBD6 | |
| LFLWMYWPSFNSAIS | 226 | Q9UBD6 | |
| WLWVISPFMAYGSAS | 131 | Q9C0K7 | |
| RWSDLPKDTFWLYFS | 96 | P16662 | |
| DYYWWLLFPVTFTAM | 201 | Q15849 | |
| MIEFWWLYLTPVTSE | 11 | Q96H15 | |
| WYMFWLLQAYECPAA | 261 | Q8NDX2 | |
| MLPLVLHWFFIEWYS | 66 | Q9P055 | |
| SWWADLNYFLSSLPF | 126 | Q6P5S2 |